What is the equity of Ardelyx this year?
Ardelyx has equity of 166.82 M USD this year.
Ardelyx Equity 2024
Ardelyx Equity
166.82 M USD
Ardelyx Dividend yield
Ticker
ARDX
ISIN
US0396971071
WKN
A116X0
In 2024, Ardelyx's equity was 166.82 M USD, a 69.7% increase from the 98.3 M USD equity in the previous year.
Ardelyx Aktienanalyse
What does Ardelyx do?
Ardelyx Inc. is a biotechnology company founded in 2007 by researchers to develop life-changing medications. The company is based in Fremont, California, USA and focuses on researching kidney and gastrointestinal diseases, as well as cardiology and metabolic disorders. Its business model is based on identifying unmet medical needs and developing drugs to meet those needs. Ardelyx works closely with patients to understand their medical problems and develop specific solutions. The company categorizes its products into three categories: kidney, gastrointestinal, and cardiology/metabolism. Ardelyx has developed a medication called Tenapanor for chronic kidney disease, which reduces phosphorus levels in the blood, lowering the risk of cardiovascular disease. For gastrointestinal diseases like irritable bowel syndrome and ulcerative colitis, Ardelyx has developed Tenapanor to reduce pain and discomfort by regulating fluid and nutrient volumes in the intestine. In the field of cardiology/metabolic disorders, Ardelyx is working on developing medications to regulate cholesterol levels and the lipid metabolism system, which can be the cause of heart disease or diabetes. The company is awaiting approval for Ibsrela, a medication for chronic constipation and pelvic floor disorders, as well as RDX013, a medication to regulate lipid metabolism. Ardelyx also benefits from collaborating with other pharmaceutical companies, such as AstraZeneca, which has supported the development of novel treatments for kidney diseases. The partnership with AstraZeneca focuses on creating treatments that prevent damage to kidney cells or the cardiovascular system. Ardelyx has also received a number of awards and recognition, demonstrating its effectiveness and performance in the biotechnology industry. For example, in 2019, Inc. Magazine included Ardelyx for the fourth consecutive year in its list of the "5000 fastest-growing private companies in the USA." This publication highlighted Ardelyx's tripling of its employee count during the same period. Overall, Ardelyx focuses on researching and developing innovative medications that meet the needs of patients with kidney, gastrointestinal, cardiology, and metabolic disorders. Despite being a young company, it already produces a range of innovative products and is committed to developing life-changing medications through its research and improving the quality of life for affected patients. Output: Ardelyx Inc. is a biotechnology company focused on developing life-changing medications for kidney, gastrointestinal, cardiology, and metabolic disorders. They collaborate with patients to understand their medical problems and develop specific solutions. They have developed medications such as Tenapanor for chronic kidney disease and gastrointestinal diseases. They are awaiting approval for medications to treat chronic constipation and pelvic floor disorders, as well as regulate lipid metabolism. Ardelyx has partnerships with other pharmaceutical companies like AstraZeneca. They have received awards for their effectiveness and performance in the biotechnology industry. Ardelyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Ardelyx's Equity
Ardelyx's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ardelyx's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Ardelyx's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Ardelyx's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Ardelyx’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Ardelyx Stock
What was the equity of Ardelyx compared to the previous year?
The equity of Ardelyx has increased/decreased by 69.7% increased compared to the previous year.
What impact does a high equity have on investors of Ardelyx?
A high equity is advantageous for investors of Ardelyx as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Ardelyx?
A low equity can be a risk for investors of Ardelyx, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Ardelyx affect the company?
An increase in equity of Ardelyx can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Ardelyx affect the company?
A reduction in equity of Ardelyx can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Ardelyx?
Some factors that can affect the equity of Ardelyx include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Ardelyx so important for investors?
The equity of Ardelyx is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Ardelyx take to change the equity?
To change equity, Ardelyx can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Ardelyx pay?
Over the past 12 months, Ardelyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ardelyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Ardelyx?
The current dividend yield of Ardelyx is .
When does Ardelyx pay dividends?
Ardelyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ardelyx?
Ardelyx paid dividends every year for the past 0 years.
What is the dividend of Ardelyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ardelyx located?
Ardelyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ardelyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ardelyx from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.
When did Ardelyx pay the last dividend?
The last dividend was paid out on 6/3/2024.
What was the dividend of Ardelyx in the year 2023?
In the year 2023, Ardelyx distributed 0 USD as dividends.
In which currency does Ardelyx pay out the dividend?
The dividends of Ardelyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ardelyx stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ardelyx
Our stock analysis for Ardelyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ardelyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
